Iambic Therapeutics

Iambic Therapeutics is a clinical-stage biotechnology company dedicated to revolutionizing drug discovery through its unique AI-driven platform. Leveraging cutting-edge physics-based AI algorithms, Iambic's technology tackles complex design problems, uncovering new chemical mechanisms and optimizing target product profiles. This platform operates at a pace years faster than industry norms, generating thousands of novel molecular designs and biological data each week, allowing the company to deliver differentiated development candidates on an accelerated timeline.

Iambic's platform has led to the discovery of a promising pipeline of clinical assets, including IAM1363, a highly selective and brain-penetrant inhibitor of HER2 currently in a Phase 1/1b study. This innovative technology has attracted significant investment, most recently securing a $50 million Series B extension to further expand its portfolio and advance its clinical programs. As a leader in AI-driven drug discovery, Iambic Therapeutics is poised to make a significant impact on the future of medicine, bringing potential life-saving treatments to patients with urgent unmet needs.

Iambic Therapeutics is a clinical-stage biotechnology company focused on disrupting the drug discovery process by leveraging its unique AI-driven platform. Their mission is to develop novel therapeutics, addressing unmet patient needs by tackling challenging design problems and creating superior medicines. They achieve this through the combination of physics-based AI algorithms, high-throughput experimentation, and automated data pipelines, allowing them to deliver differentiated clinical candidates at a significantly faster pace than industry standards.

Iambic Therapeutics fosters a culture that values audacious thinking, mutual respect, and collaborative problem-solving. They encourage diverse viewpoints and empower employees to seek out the right answers from the right people, fostering an innovative and collaborative environment where individuals can contribute to changing the landscape of small molecule discovery.

Iambic Therapeutics values a diverse range of viewpoints and backgrounds, recognizing that diverse perspectives strengthen their work. They foster an inclusive environment where individuals feel empowered to contribute their unique skills and perspectives, embracing collaboration and open communication across their teams. This dedication to diversity, equity, and inclusion is reflected in their leadership, scientific & clinical advisory board, and their commitment to building a company culture that values respect and collaboration.